Our recent in vivo study demonstrated the antitumor and antivascular effects of intratumoral GET with plasmid DNA-encoding shRNA against MCAM in melanoma B16F10, which resulted in significant tumor growth delay and 17% of tumor cures [15]. This evidence concerns the gene MCAM and neoplasm.